thymoquinone has been researched along with tetradecanoylphorbol acetate in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Kundu, JK; Liu, L; Shin, JW; Surh, YJ | 1 |
| Kohno, S; Kumar, S; Linn, P; Nagatani, N; Soga, T; Takahashi, C; Watanabe, Y | 1 |
3 other study(ies) available for thymoquinone and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
Thymoquinone inhibits phorbol ester-induced activation of NF-κB and expression of COX-2, and induces expression of cytoprotective enzymes in mouse skin in vivo.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Benzoquinones; Cyclooxygenase 2; Cytoprotection; Female; Gene Expression Regulation; JNK Mitogen-Activated Protein Kinases; Mice; Mice, Hairless; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Skin; Tetradecanoylphorbol Acetate | 2013 |
Pharmacologically targetable vulnerability in prostate cancer carrying RB1-SUCLA2 deletion.
Topics: Animals; Apoptosis; Benzoquinones; Cell Line, Tumor; Gene Deletion; HEK293 Cells; Humans; Male; Mice, Knockout; Mice, Nude; Mice, SCID; PC-3 Cells; Prostatic Neoplasms; Retinoblastoma Protein; Succinate-CoA Ligases; Tetradecanoylphorbol Acetate | 2020 |